The role of estrogen receptor β (ERβ) in malignant diseases-A new potential target for antiproliferative drugs in prevention and treatment of cancer

Biochemical and Biophysical Research Communications

Volumn 396, Issue 1, 2010, Pages 63-66

  Warner, Margaret ^a,b   Gustafsson, Jan Åke ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b University of Houston   (United States)

Author keywords

Antiproliferative; Cancer; Drug; Gene expression; Nuclear receptor; Pharmaceutical; Transcription

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA STIMULATING AGENT; HORMONE RECEPTOR STIMULATING AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; DRUG SPECIFICITY; DRUG TARGETING; GENE EXPRESSION REGULATION; HORMONE SUBSTITUTION; HUMAN; IMMUNOSURVEILLANCE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TUMOR IMMUNITY; WATCHFUL WAITING;

ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; ESTROGEN RECEPTOR BETA; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; IMMUNOLOGIC SURVEILLANCE; MALE; PROSTATIC NEOPLASMS;

EID: 77952302285     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.144     Document Type: Article

References (43)

1. Bai Z., and Gust R. Breast cancer, estrogen receptor and ligands. Arch. Pharm. (Weinheim) 342 (2009) 133-149
2. Fitzpatrick J.M., Schulman C., Zlotta A.R., and Schröder F.H. Prostate cancer: a serious disease suitable for prevention. BJU Int. 103 (2009) 864-870
3. Janakiram N.B., Steele V.E., and Rao C.V. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats. Cancer Prev. Res. (Phila Pa) 2 (2009) 52-59
4. Chandanos E., and Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur. J. Cancer 44 (2008) 2397-2403
5. Molica S. Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk. Lymphoma 47 (2006) 1477-1480
6. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93 (1996) 5925-5930
7. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., and Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 30 (2000) 311-317
8. Sugiura H., Toyama T., Hara Y., Zhang Z., Kobayashi S., Fujii Y., Iwase H., and Yamashita H. Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer. Jpn. J. Clin. Oncol. 37 (2007) 820-828
9. Suzuki F., Akahira J., Miura I., Suzuki T., Ito K., Hayashi S., Sasano H., and Yaegashi N. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma. Cancer Sci. 99 (2008) 2365-2372
10. Bonkhoff H., and Berges R. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur. Urol. 55 (2008) 533-542
11. Walf A.A., Koonce C.J., and Frye C.A. Estradiol or diarylpropionitrile decreases anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. Behav. Neurosci. 122 (2008) 974-981
12. Gardell L.R., Hyldtoft L., Del Tredici A.L., Andersen C.B., Fairbairn L.C., Lund B.W., Gustafsson M., Brann M.R., Olsson R., and Piu F. Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist. Eur. J. Pharmacol. 592 (2008) 158-159
13. Hughes Z.A., Liu F., Platt B.J., Dwyer J.M., Pulicicchio C.M., Zhang G., Schechter L.E., Rosenzweig-Lipson S., and Day M. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology 54 (2008) 1136-1142
14. Cristofaro P.A., Opal S.M., Palardy J.E., Parejo N.A., Jhung J., Keith Jr. J.C., and Harris H.A. WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. Crit. Care Med. 34 (2006) 2188-2193
15. Elloso M., Phiel K., Henderson R.A., Harris H.A., and Adelman S.J. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J. Endocrinol. 185 (2005) 243-252
16. Harris H.A., Albert L.M., Leathurby Y., Malamas M.S., Mewsha R.E., Miller C.P., Kharode Y.P., Marzolf J., Komm B.S., Winneker R.C., Frail D.E., Henderson R.A., Zhu Y., and Keith Jr. J.C. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144 (2003) 4241-4249
17. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Ström A., Treuter E., Warner M., and Gustafsson J.-A. Estrogen receptors: how do they signal and what are their targets?. Physiol. Rev. 87 (2007) 905-931
18. Blizzard T.A. Selective estrogen receptor modulator medicinal chemistry at Merck. A review,. Curr. Top. Med. Chem. 8 (2008) 792-812
19. Jordan V.C.A. Century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention. Cancer Res. 69 (2009) 1243-1254
20. Cheng G., Weihua Z., Warner M., and Gustafsson J.-A. Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland. Proc. Natl. Acad. Sci. USA 101 (2004) 3739-3746
21. Wada-Hiraike O., Hiraike H., Okinaga H., Imamov O., Barros R.P., Morani A., Omoto Y., Warner M., and Gustafsson J.-A. Role of estrogen receptor beta in uterine stroma and epithelium: insights from estrogen receptor beta-/- mice. Proc. Natl. Acad. Sci. USA 103 (2006) 18350-18355
22. Omoto Y., Imamov O., Warner M., and Gustafsson J.-A. Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen. Proc. Natl. Acad. Sci. USA 102 (2005) 1484-1489
23. Imamov O., Morani A., Shim G.J., Omoto Y., Thulin-Andersson C., Warner M., and Gustafsson J.-A. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl. Acad. Sci. USA 101 (2004) 9375-9380
24. Cheng G., Li Y., Omoto Y., Wang Y., Berg T., Nord M., Vihko P., Warner M., Piao Y.S., and Gustafsson J.-A. Differential regulation of estrogen receptor (ER) alpha and ERbeta in primate mammary gland. J. Clin. Endocrinol. Metab. 90 (2005) 435-444
25. Wada-Hiraike O., Imamov O., Hiraike H., Hultenby K., Schwend T., Omoto Y., Warner M., and Gustafsson J.-A. Role of estrogen receptor beta in colonic epithelium. Proc. Natl. Acad. Sci. USA 103 (2006) 2959-2964
26. Morani A., Barros R.P., Imamov O., Hultenby K., Arner A., Warner M., and Gustafsson J.-A. Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice. Proc. Natl. Acad. Sci. USA 103 (2006) 7165-7169
27. Shim G.J., Wang L., Andersson S., Nagy N., Kis L.L., Zhang Q., Mäkelä S., Warner M., and Gustafsson J.-A. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. USA 100 (2003) 6694-6699
28. Paju A., Hotakainen K., Cao Y., Laurila T., Gadaleanu V., Hemminki A., Stenman U.H., and Bjartell A. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells. Eur. Urol. 52 (2007) 1670-1679
29. Hartman J., Lindberg K., Morani A., Inzunza J., Ström A., and Gustafsson J.-A. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res. 66 (2006) 11207-11213
30. Zhao C., Lam E.W., Sunters A., Enmark E., De Bella M.T., Coombes R.C., Gustafsson J.-A., and Dahlman-Wright K. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene 22 (2003) 7600-7606
31. Stettner M., Kaulfuss S., Burfeind P., Schweyer S., Strauss A., Ringert R.H., and Thelen P. The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment. Mol. Cancer Ther. 6 (2007) 2626-2633
32. Shim G.J., Gherman D., Kim H.J., Omoto Y., Iwase H., Bouton D., Kis L.L., Andersson C.T., Warner M., and Gustafsson J.-A. Differential expression of oestrogen receptors in human secondary lymphoid tissues. J. Pathol. 208 (2006) 408-414
33. Carlsten H., Tarkowski A., Holmdahl R., and Nilsson L.A. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin. Exp. Immunol. 80 (1990) 467-473
34. Jiang X., Ellison S.J., Alarid E.T., and Shapiro D.J. Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 26 (2007) 4106-4114
35. Ogawa S., Inoue S., Watanabe T., Orimo A., Hosoi T., Ouchi Y., and Muramatsu M. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human. Nucleic Acids Res. 1 (1998) 3505-3512
36. Honma N., Horii R., Iwase T., Saji S., Younes M., Takubo K., Matsuura M., Ito Y., Akiyama F., and Sakamoto G. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J. Clin. Oncol. 1 (2008) 3727-3734
37. Fujimura T., Takahashi S., Urano T., Ogawa S., Ouchi Y., Kitamura T., Muramatsu M., and Inoue S. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer. Biochem. Biophys. Res. Commun. 289 (2001) 692-699
38. I. Nalvarte, T. Schwend, J.-A. Gustafsson, Proteomic analysis of the estrogen receptor alpha receptosome, Mol. Cell. Proteomics, in press.
39. Shim G.J., Kis L.L., Warner M., and Gustafsson J.-A. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc. Natl. Acad. Sci. USA 101 (2004) 1720-1724
40. Shim G.J., Warner M., Kim H.J., Andersson S., Liu L., Ekman J., Imamov O., Jones M.E., Simpson E.R., and Gustafsson J.-A. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc. Natl. Acad. Sci. USA 101 (2004) 12628-12633
41. Beeson P.B. Age and sex associations of 40 autoimmune diseases. Am. J. Med. 96 (1994) 457-462
42. Chiorazzi N., Hatzi K., and Albesiano E. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto) antigens. Ann. N.Y. Acad. Sci. 1062 (2005) 1-12
43. Palma M., Kokhaei P., Lundin J., Choudhury A., Mellstedt H., and Osterborg A. The biology and treatment of chronic lymphocytic leukemia. Ann. Oncol. 17 Suppl. 10 (2006) x144-x154